Segantii Capital Management LTD Pfizer Inc Transaction History

Segantii Capital Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$35.91 - $40.68 $11.7 Million - $13.3 Million	-326,936 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $1.24 Million - $1.4 Million	36,936 Added 12.74%	326,936 $11.8 Million
Q4 2020 Jan 27, 2021	BUY	$33.47 - $42.56 $9.71 Million - $12.3 Million	290,000 New	290,000 $10.7 Million
Q4 2017 Feb 08, 2018	SELL	$33.26 - $35.29 $2 Million - $2.12 Million	-60,000 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$31.0 - $34.15 $1.86 Million - $2.05 Million	60,000	60,000 $2.14 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Segantii Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Segantii Capital Management LTD with notifications on news.